The dual flow cell configuration of Illumina’s NovaSeq X Plus

BY Reuters • August 6, 2024

FILE PHOTO: The dual flow cell configuration of Illumina’s NovaSeq X Plus is shown in this undated handout photo obtained by Reuters September 28, 2022. Illumina Inc/Handout via REUTERS/File Photo

« Illumina expects full-year sales from core segment to decline on biotech funding crunch